| 摘要 |
<p>The present invention is directed to a method for the in vitro preparation of cardiac progenitors cells from primate embryonic stem cells (ES cells) wherein said method comprises the use of the CD15 (SSEAI) marker as a positive cardiac progenitors differentiation marker. The present invention also claimed the use of a receptor tyrosine kinase inhibitor, particularly the SU5402 or SU11248 in association with the BMP2 for improving the efficiency of the desired differentiation. The present invention is also directed to the use of platelet lysate as foetal animal serum substitute in a culture medium intended to the proliferation or propagation of primate ES cells maintaining their pluripotency feature. Derived compositions or kits in relation with the claimed methods or product obtainable by the claimed methods form also part of the present invention.</p> |
